Phase I Study Evaluating Tolerability, Safety, Pharmacokinetics, and Efficacy of Combined ONO-4059 and R-MPV Therapy for PCNSL
Clinical trial NCT06541665 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06541665
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-17
- Primary completion
- 2028-04-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.